Ongoing studies are exploring its effects on: Non-Alcoholic Steatohepatitis (NASH) : Preliminary research suggests Semaglutide could help treat NASH, a serious liver condition linked to obesity and type 2 diabetes
is supported, in part, by a Banting and Best Diabetes CentreNovo Nordisk Chair in Incretin Biology, a Sinai HealthNovo Nordisk Foundation Fund in Regulatory Peptides, CIHR grants 154321 and 19204 and Diabetes Canada-Canadian Cancer Society grant (OG-3- 24-5819-DD)
Most patients begin with a low dose, gradually increasing over time to reach their ideal therapeutic level
Both reduce appetite and are used alongside diet and activity changes, but current NICE guidance concludes that tirzepatide is more effective overall than semaglutide for managing overweight and obesity
Biotin is a B vitamin that helps the body convert food into energy and supports the production of keratin, which is essential for healthy hair, skin, and nails